These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Specificity of Immunoglobulin Response to Nontuberculous Mycobacteria Infection in People with Cystic Fibrosis. Malcolm KC; Wheeler EA; Calhoun K; Lenhart-Pendergrass PM; Rysavy N; Poch KR; Caceres SM; Saavedra MT; Nick JA Microbiol Spectr; 2022 Aug; 10(4):e0187422. PubMed ID: 35863022 [TBL] [Abstract][Full Text] [Related]
3. Incidence of nontuberculous mycobacteria infections among persons with cystic fibrosis in the United States (2010-2019). Marshall JE; Mercaldo RA; Lipner EM; Prevots DR BMC Infect Dis; 2023 Jul; 23(1):489. PubMed ID: 37488500 [TBL] [Abstract][Full Text] [Related]
4. Investigating Nontuberculous Mycobacteria Transmission at the Colorado Adult Cystic Fibrosis Program. Gross JE; Caceres S; Poch K; Hasan NA; Jia F; Epperson LE; Lipner E; Vang C; Honda JR; Strand M; Calado Nogueira de Moura V; Daley CL; Strong M; Davidson RM; Nick JA Am J Respir Crit Care Med; 2022 May; 205(9):1064-1074. PubMed ID: 35085056 [No Abstract] [Full Text] [Related]
5. Molecular Epidemiologic Investigation of Gross JE; Teneback CC; Sweet JG; Caceres SM; Poch KR; Hasan NA; Jia F; Epperson LE; Lipner EM; Vang CK; Honda JR; Strand MJ; Calado Nogueira de Moura V; Daley CL; Strong M; Davidson RM; Nick JA Ann Am Thorac Soc; 2023 May; 20(5):677-686. PubMed ID: 36656594 [No Abstract] [Full Text] [Related]
7. Prospective evaluation of nontuberculous mycobacteria disease in cystic fibrosis: The design of the PREDICT study. Martiniano SL; Caceres SM; Poch K; Rysavy NM; Lovell VK; Armantrout E; Jones M; Anthony M; Keck A; Nichols DP; Vandalfsen JM; Sagel SD; Wagner B; Xie J; Weaver K; Heltshe SL; Daley CL; Davidson RM; Nick JA; J Cyst Fibros; 2024 Jan; 23(1):50-57. PubMed ID: 37666709 [TBL] [Abstract][Full Text] [Related]
8. Epidemiological trends in nontuberculous mycobacterial infection among people with cystic fibrosis in Germany. Steindor M; Hafkemeyer S; Ruckes C; Stehling F; Naehrlich L; Ringshausen FC Int J Infect Dis; 2023 Apr; 129():32-39. PubMed ID: 36736578 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology of Pulmonary Nontuberculous Mycobacterial Sputum Positivity in Patients with Cystic Fibrosis in the United States, 2010-2014. Adjemian J; Olivier KN; Prevots DR Ann Am Thorac Soc; 2018 Jul; 15(7):817-826. PubMed ID: 29897781 [TBL] [Abstract][Full Text] [Related]
10. Tissue-localized immune responses in people with cystic fibrosis and respiratory nontuberculous mycobacteria infection. Hayes D; Shukla RK; Cheng Y; Gecili E; Merling MR; Szczesniak RD; Ziady AG; Woods JC; Hall-Stoodley L; Liyanage NP; Robinson RT JCI Insight; 2022 Jun; 7(12):. PubMed ID: 35536650 [TBL] [Abstract][Full Text] [Related]
11. Prospective healthcare-associated links in transmission of nontuberculous mycobacteria among people with cystic fibrosis (pHALT NTM) study: Rationale and study design. Gross JE; Caceres S; Poch K; Epperson LE; Hasan NA; Jia F; Calado Nogueira de Moura V; Strand M; Lipner EM; Honda JR; Strong M; Davidson RM; Daley CL; Nick JA PLoS One; 2023; 18(12):e0291910. PubMed ID: 38117792 [TBL] [Abstract][Full Text] [Related]
12. Nontuberculous mycobacteria in cystic fibrosis: Updates and the path forward. Martiniano SL; Davidson RM; Nick JA Pediatr Pulmonol; 2017 Nov; 52(S48):S29-S36. PubMed ID: 28881094 [TBL] [Abstract][Full Text] [Related]
13. Healthcare-associated links in transmission of nontuberculous mycobacteria among people with cystic fibrosis (HALT NTM) study: Rationale and study design. Gross JE; Caceres S; Poch K; Hasan NA; Davidson RM; Epperson LE; Lipner E; Vang C; Honda JR; Strand M; Strong M; Saiman L; Prevots DR; Olivier KN; Nick JA PLoS One; 2021; 16(12):e0261628. PubMed ID: 34929010 [TBL] [Abstract][Full Text] [Related]
14. Nontuberculous mycobacterial infection and environmental molybdenum in persons with cystic fibrosis: a case-control study in Colorado. Lipner EM; Crooks JL; French J; Strong M; Nick JA; Prevots DR J Expo Sci Environ Epidemiol; 2022 Mar; 32(2):289-294. PubMed ID: 34218259 [TBL] [Abstract][Full Text] [Related]
15. Nontuberculous mycobacterial infections in cystic fibrosis. Martiniano SL; Nick JA Clin Chest Med; 2015 Mar; 36(1):101-15. PubMed ID: 25676523 [TBL] [Abstract][Full Text] [Related]
16. Epidemiology and management of nontuberculous mycobacterial disease in people with cystic fibrosis, the Netherlands. Zomer D; van Ingen J; Hofland R; J Cyst Fibros; 2023 Mar; 22(2):327-333. PubMed ID: 36347785 [TBL] [Abstract][Full Text] [Related]